Autologous hematopoietic stem cell transplantation was used for treatment of 384 patients with multiple myeloma in 37 centers during the years 1986-1994.
People also ask
How successful is autologous stem cell transplant for multiple myeloma?
What is the success rate of autologous bone marrow transplant?
Is autologous stem cell transplant a bone marrow transplant?
Is bone marrow transplant successful in multiple myeloma?
We conclude that autografting in myeloma is most effective when applied early in the course of disease in younger, chemotherapy-responsive patients. Alpha- ...
Autologous hematopoietic stem cell transplantation was used for treatment of 384 patients with multiple myeloma in 37 centers during the years 1986–1994.
Among autologous transplant patients, the median survival after transplantation is 50 months, and the actuarial survival at 10 years is 30%, with a plateau ...
Autologous Stem Cell Transplantation in Multiple Myeloma: Results of the European Group for Bone Marrow Transplantation. B. Bjiirkstrand," P, Ljungman ...
Autologous stem cell transplant can provide a deep response with long-term remission. A deep response, having no minimal residual disease (MRD), also known as ...
Among autologous transplant patients, the median survival after transplantation is 50 months, and the actuarial survival at 10 years is 30%, with a plateau ...
Apr 8, 2019 · PFS and OS were significantly improved after a second transplant, with approximately 30% reduction in the risk of death and progression. Updated ...
Jul 11, 1996 · High-dose therapy combined with transplantation improves the response rate, event-free survival, and overall survival in patients with myeloma.
Tandem autologous transplant improves survival in NDMM EMD with high-risk cytogenetics in comparison with single transplant.